Stroz Medical and Seimens Healthlineers entered into a sale partnership agreement for the extracorporeal shock wave lithotripsy market

Stroz Medical and Seimens Healthlineers entered into a sale partnership agreement for the extracorporeal shock wave lithotripsy market

According to the National Kidney Foundation, 1 in 3 adults in the U.S. (approximately 80 million) is at risk for kidney disease. Kidney disease is more common in women (14%) than men (12%). But for every 2 women who develop end-stage kidney disease (ESKD), 3 men's kidneys fail. Kidney disease is a leading cause of death in the U.S. Extracorporeal shock wave lithotripsy is majorly used in the treatment of kidney stones. It eradicates stones from the kidney, gallbladder, ureter, and salivary gland. Moreover, it is used to detect stone and break it down into smaller fragments. Also, it is effective in the treatment of non-obstructing renal calculi. Such advantages is expected to facilitate the growth of the extracorporeal shock wave lithotripsy market

1. In 2018, Stroz Medical and Seimens Healthlineers entered into a sale partnership agreement for the development of powerful extracorporeal shock wave lithotripsy (ESWL) technology. This technology is in development for the removal of stones from the entire urinary tract by combining the mobile C-arms technology in the Cios family

2. In March 2020, Extracorporeal Shock Wave Lithotripsy (ESWL) was launched at M Yunus Regional Hospital in Benkulu, Indonesia in order to provide proper and improvised health services to the people of Bengkulu, Indonesia.

3. In 2018, Stroz Medical and Seimens Healthlineers entered into a sale partnership agreement for the development of powerful extracorporeal shock wave lithotripsy (ESWL) technology. This technology is in development for the removal of stones from the entire urinary tract by combining the mobile C-arms technology in the Cios family

Europe is expected to hold a dominant position in the global extracorporeal shock wave lithotripsy market owing to the increasing launch of the innovative product by key players in the region. For instance, in September 2019, Dornier MedTech, launched the new OptiVision technology for the Dornier Delta III, and extracorporeal shock wave lithotripsy (ESWL). The OptiVision is the first image processing software developed to enhance the efficiency of kidney stone treatment, i.e., visualization of the steps of processing the kidney stone during the extracorporeal shock wave lithotripsy that may help in more successful treatment.

Extracorporeal shock wave lithotripsy is a medical procedure that involves passing high voltage, low-frequency electrical pulses through the body of patients suffering from kidney stones. Kidney stones, also known as renal calculi, are masses of crystallized urine that accumulate in the kidneys, causing pain and swelling. Although these stones do not normally cause death, their presence in the urinary tract can create unbearable pain for the patient and his family.


Post a Comment

Previous Post Next Post